Vivoverse Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$600K
- Investors
-
7
Vivoverse General Information
Description
Operator of AI-powered biological screening platforms intended to support drug discovery, toxicology testing, and chemical safety assessment. The company offers microfluidics, automated 3D imaging, and artificial intelligence technologies for whole-organism phenotypic analysis using C. elegans, enabling pharmaceutical companies, biotechnology firms, and research institutions to conduct preclinical testing and toxicity assessments while reducing reliance on traditional animal studies.
Contact Information
Website
www.vivoverse.comCorporate Office
- 3303 Northland Drive
- Suite 308
- Austin, TX 78731
- United States
Corporate Office
- 3303 Northland Drive
- Suite 308
- Austin, TX 78731
- United States
Vivoverse Timeline
Vivoverse Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 17-Dec-2024 | $600K | Completed | Generating Revenue | ||
| 9. Grant | 05-Aug-2023 | Completed | Generating Revenue | |||
| 8. Grant | 15-Jul-2021 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jul-2020 | Completed | Generating Revenue | |||
| 6. Grant | 01-Apr-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 29-Oct-2018 | Completed | Generating Revenue | |||
| 4. Grant | 14-Sep-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 21-Feb-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 11-Sep-2017 | Completed | Generating Revenue | |||
| 1. Grant | 18-Apr-2017 | $31K | Completed | Generating Revenue |
Vivoverse Patents
Vivoverse Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4690102-A1 | Method and compositions for analyzing toxicity in organisms | Pending | 24-Mar-2023 | ||
| US-20260266805-A1 | Method and compositions for analyzing toxicity in organisms | Pending | 24-Mar-2023 | ||
| WO-2024206236-A1 | Method and compositions for analyzing toxicity in organisms | Inactive | 24-Mar-2023 | G01N15/1433 |
Vivoverse Signals
Vivoverse Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute of Environmental Health Sciences | Government | |||
| ACC Bioscience Incubator | Accelerator/Incubator | |||
| U.S. Department of Health and Human Services | Government | |||
| MassChallenge | Accelerator/Incubator | |||
| Texas Venture Labs | University | Minority |
Vivoverse FAQs
-
When was Vivoverse founded?
Vivoverse was founded in 2016.
-
Where is Vivoverse headquartered?
Vivoverse is headquartered in Austin, TX.
-
What is the size of Vivoverse?
Vivoverse has 10 total employees.
-
What industry is Vivoverse in?
Vivoverse’s primary industry is Other Devices and Supplies.
-
Is Vivoverse a private or public company?
Vivoverse is a Private company.
-
What is Vivoverse’s current revenue?
The current revenue for Vivoverse is .
-
Who are Vivoverse’s investors?
National Institute of Environmental Health Sciences, ACC Bioscience Incubator, U.S. Department of Health and Human Services, MassChallenge, and Texas Venture Labs are 5 of 7 investors who have invested in Vivoverse.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process